Edition:
United Kingdom

Exact Sciences Corp (EXAS.OQ)

EXAS.OQ on NASDAQ Stock Exchange Capital Market

77.09USD
15 Jan 2019
Change (% chg)

$3.51 (+4.77%)
Prev Close
$73.58
Open
$73.99
Day's High
$78.05
Day's Low
$73.71
Volume
472,936
Avg. Vol
567,126
52-wk High
$82.83
52-wk Low
$37.39

Chart for

About

Exact Sciences Corporation is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA)... (more)

Overall

Beta: 0.64
Market Cap(Mil.): $5,791.66
Shares Outstanding(Mil.): 119.10
Dividend: --
Yield (%): --

Financials

  EXAS.OQ Industry Sector
P/E (TTM): -- 69.71 34.38
EPS (TTM): -1.29 -- --
ROI: -34.68 8.99 14.96
ROE: -35.62 10.14 16.53

Exact Sciences surges after marketing deal with Pfizer for cancer test

Exact Sciences Corp's shares shot up as much as 26 percent on Wednesday after the company said Pfizer Inc would share marketing expenses and co-promote the company's stool screening test for colorectal cancer.

22 Aug 2018

UPDATE 1-Exact Sciences surges after marketing deal with Pfizer for cancer test

Aug 22 Exact Sciences Corp's shares shot up as much as 26 percent on Wednesday after the company said Pfizer Inc would share marketing expenses and co-promote the company's stool screening test for colorectal cancer.

22 Aug 2018

Exact Sciences signs marketing deal with Pfizer for cancer test

Aug 22 Exact Sciences Corp said on Wednesday Pfizer Inc would share marketing expenses and co-promote the company's stool screening test for colorectal cancer, in a bid to boost sales of the product.

22 Aug 2018

Earnings vs. Estimates